Earlier studies in INSS stage 4 NB patients that were in complete/partial remission who were administrated high doses of IL-2 showed a biphasic response: in the initial stages of the treatments, there was an increase in NK cell proliferation, followed by increased NK cell-induced cytotoxicity during the later stages [24]. This evidence concerns the gene IL2 and neuroblastoma.